在肿瘤中的意义(3) - 实用肿瘤杂志杂志社投稿_期刊论文发表|版面费|电话|编辑部- 实用肿瘤杂志

一、本刊要求作者有严谨的学风和朴实的文风，提倡互相尊重和自由讨论。凡采用他人学说，必须加注说明。二、不要超过10000字为宜，精粹的短篇，尤为欢迎。三、请作者将稿件（用WORD格式）发送到下面给出的征文信箱中。四、凡来稿请作者自留底稿，恕不退稿。五、为规范排版，请作者在上传修改稿时严格按以下要求： 1．论文要求有题名、摘要、关键词、作者姓名、作者工作单位（名称，省市邮编）等内容一份。 2．基金项目和作者简介按下列格式：基金项目：项目名称（编号）作者简介：姓名（出生年－），性别，民族（汉族可省略），籍贯，职称，学位，研究方向。 3．文章一般有引言部分和正文部分，正文部分用阿拉伯数字分级编号法，一般用两级。插图下方应注明图序和图名。表格应采用三线表，表格上方应注明表序和表名。 4．参考文献列出的一般应限于作者直接阅读过的、最主要的、发表在正式出版物上的文献。其他相关注释可用脚注在当页标注。参考文献的著录应执行国家标准GB7714-87的规定，采用顺序编码制。

在肿瘤中的意义(3)

作者:

关键词:

摘要：

IER3是一个重要但真正未被研究的基因。它在癌细胞中的去调节作用，再加上它在细胞凋亡、存活和生长中的关键作用，强调了它在癌症发病机制中的作用。然而，使用IER3作为癌症预后的生物标志物仍然是一个巨大的挑战，因为IER3的确切分子作用仍然是难以捉摸的；目前还没有一个标准化的检测方法用于临床筛查IER3的表达，而且我们对其复杂的细胞功能的潜在机制了解太少。希望在以后的科研工作中能够对IER3进行更多的研究，IER3有望成为一个有意义的生物标记物。

[1]Wu MX. Roles of the stress-induced gene IER3 in regulation of cell death and oncogenesis[J]. Apoptosis,2003,8(1):11-18.

[2]Arlt A, Schafer H. Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis[J].Eur J Cell Biol,2011,90(6):545-552.

[3]Ustyugova, IV, Zhi, L,Abramowitz, J, et al.IER3 deficiency protects against colonic cancer[J].Mol Cancer Res,2012,10(6):760-7.

[4]Shen L, Zhi L, Hu W, et al. IER3 targets mitochondrial F1Fo-ATPaseinhibitor for degradation[J]. Cell Death Differ,2009,16:603-12.

[5]Schulze, PC,de Keulenaer, GW, Kassik, KA,et induced gene IER3 inhibits vascular smooth muscle cell proliferation and neointima formation[J].Circ Res,2003,93(12):1210-1217.

[6]Sina, C, Arlt, A, Gavrilova, O,et of gly96/immediate early gene-X1 (gly96/IER3) aggravates DSS-induced colitis in mice: role for gly96/IER3 in the regulation of NF-kappaB[J].Inflamm Bowel Dis,2010,16(2):320-331.

[7]Schilling, D, Pittelkow, MR,Kumar, R.IER3, an immediate early gene, increases the rate of apoptosis in keratinocytes[J].Oncogene,2001,20(55):7992-7997.

[8]Arlt, A, Grobe, O, Sieke, A, et of the NFkappa B target gene IER3 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells[J].Oncogene,2001,20(1):69-76.

[9]You, F,Osawa, Y, Hayashi, S,et early gene IER3 induces astrocytic differentiation of U87-MG human glioma cells[J].J Cell Biochem,2007,100(1):256-265.

[10]Arlt, A,Minkenberg, J,Kocs, B,et al.The expression of immediate early gene X-1 (IER3) is differentially induced by retinoic acids in NB4 and KG1 cells: possible implication in the distinct phenotype of retinoic acid-responsive and -resistant leukemic cells[J].Leukemia,2004,18(10):1646-1655.

[11]Campanella M, Casswell E, Chong S, et al. Regulation of mitochondrial structure and function by the F1Fo-A TPase inhibitor pro? Ferrata Storti Foundation tein, IF1[J]. Cell Metab,2008,8(1):13-25.

[12]Noonan, EJ; Place, RF; Pookot, D; et targets HDAC-1 and induces growth arrest in prostate cancer[J].Oncogene,2009,28(14):1714-1724.

[13]Li X,Liu J, Zhou R,et al .Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation[J].Br J Haematol,2010,148(1):69-79.

[14]Shen, L, Zhi, L, Hu, W, et al.IER3 targets mitochondrial F1Fo-ATPase inhibitor for degradation[J].Cell Death Differ,2009,16(4):603-6012.

[15]Zhang, Y, Finegold, MJ, Porteu, F, et of T-cell lymphomas in Emu-IER3 mice[J].Oncogene,2003,22(44):6845-6851.

[16]Garcia, MN, Grasso, D, Lopez-Millan, MB, et al.IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation[J].J Clin Invest,2014,124(11):4709-4722.

[17]Bandres, E, Agirre, X, Bitarte, N, et regulation of microRNA expression in colorectal cancer[J].Int J Cancer,2009,125(11):2737-2743.

[18]Han, L, Geng, L, Liu, X, et significance of IER3 expression in ovarian carcinoma[J].Ultrastruct Pathol,2011,35(6):260-266.

[19]Sasada, T, Azuma, K, Hirai, T, et significance of the immediate early response gene X-1 (IER3) expression in pancreatic cancer[J].Ann Surg Oncol,2008,15(2):609-6917.

[20]Steensma, DP, Neiger, JD, Porcher, JC, et and amplification of IER3 (IER3) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes[J].Cancer Res,2009,69(19):7518-7523.

[21]Davids, MS, Steensma, DP. The molecular pathogenesis of myelodysplastic syn-dromes[J].Cancer Biol Ther,2010,10(4):309-319.

[22]Yang, C,Trent, S,Ionescu-Tiba, V,et al. Identification of cyclin D1- and estrogen-regulated genes contributing to breast carcinogenesis and progression[J].Cancer Res,2006,66(24):-.

[23]Formentini, L,Sánchez-Aragó, M, Sánchez-Cenizo, L, et al.The mitochondrial AT-Pase inhibitory factor 1 triggers a ROSmediated retrograde prosurvival and proliferative response[J].Mol Cell,2012,45(6):731-742.

[24]Sánchez-Cenizo, L, Formentini, L, Aldea, M, et of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tu-mors mediates the metabolic shift of cancer cells to a Warburg phenotype[J].J Biol Chem,2010,285(33):-.

[25]Ward, PS,Thompson, CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate[J].Cancer Cell,2012,21(3):297-308.

[26]Chariot, A, Castronovo, V. Detection of HOXA1 expression in human breast cancer[J].Biochem Biophys Res Commun,1996,222(2):292-297.

文章来源：《实用肿瘤杂志》网址: http://www.syzlzz.cn/qikandaodu/2021/0718/1207.html